Update shared on22 Aug 2025
Fair value Decreased 6.10%Despite slightly improved revenue growth forecasts and a modest decline in the future P/E ratio, analysts have lowered Leonteq’s consensus price target from CHF20.50 to CHF19.25.
What's in the News
- Leonteq approved significant changes to its Articles of Association and a substantial reduction in maximum executive committee compensation for 2026.
- At an Extraordinary General Meeting, major proposals including bylaw changes were approved.
- Leonteq expanded its partnership with BX Swiss, becoming the exclusive market maker for ETPs and completing the transfer of market maker activities from Lang & Schwarz.
- Leonteq entered a new partnership with Emirates Islamic to co-develop and distribute Shari’a-compliant structured products in the UAE, leveraging its issuance platform and technology.
Valuation Changes
Summary of Valuation Changes for Leonteq
- The Consensus Analyst Price Target has fallen from CHF20.50 to CHF19.25.
- The Consensus Revenue Growth forecasts for Leonteq has risen slightly from 13.4% per annum to 13.9% per annum.
- The Future P/E for Leonteq has fallen slightly from 6.80x to 6.57x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.